Sanofi-Regeneron Extends its Generous Support of the DF Research Award Program

The Dermatology Foundation is pleased to be the recipient of a $600,000 contribution to its Research Award Program from Sanofi and Regeneron for a new unique mid-career award. The substantial donation will support two exceptional mid-career investigators conducting research into Type 2 inflammation in skin beginning in 2026.

The supported research projects are expected to generate new insights that advance understanding of dermatologic conditions associated with Type 2 inflammation. Recipients of the DF Sanofi Regeneron Type 2 Inflammation Research Award will each receive $100,000 in annual funding for up to three years, beginning in 2026.

Although atopic dermatitis and related conditions were among the first skin disorders linked to Type 2 inflammation, recent research shows that Type 2 signatures are present in a broader range of skin disorders, including prurigo nodularis, bullous pemphigoid and inflammaging. The DF Sanofi Regeneron Type 2 Inflammation Research Award will enable mid-career investigators to drive discoveries into the pathogenesis of these disorders.

Eligibility requirements:

• A mid-career investigator who demonstrates a strong commitment to research, with at least 75% of their time dedicated to research activities.
• Has received appropriate training and experience in relevant areas of research.
• Holds a faculty appointment in an accredited dermatology department or division, within 12 years of their initial appointment as an Assistant Professor.
• Possesses an MD, DO, MD/PhD, or PhD degree.

The DF Sanofi Regeneron Type 2 Inflammation Research Award is designed to accelerate research into Type 2-related skin disorders by providing critical funding to mid-career investigators. “With this latest addition to our research awards program, we have expanded our ability to support talented researchers at a pivotal point in their careers,” said DF President Janet A. Fairley, MD. “The Sanofi and Regeneron grant strengthens the Foundation’s efforts to attract and retain skilled investigators dedicated to advancing our understanding of skin immunity disorders.”

Specific details regarding the DF Sanofi Regeneron Type 2 Inflammation Research Award will be available online this summer.

About DF Research Awards
For sixty years, the DF has been a major force in the development of the specialty’s scientific base. To date, the DF has awarded more than 2,568 research awards to enable advancements in patient care by providing more than $88.4M in funding for discovery to talented investigators. The Foundation has a proven track record of funding novel ideas and individuals who are dedicated to expanding the understanding of dermatologic diseases and conditions.

About the Dermatology Foundation
Founded in 1964, the Dermatology Foundation is a 501(c)(3) organization and the leading private funding source for skin disease research in the US.